Business Wire

Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief ...
Business Insider

Bio-Rad price target lowered to $409 from $430 at RBC Capital

RBC Capital lowered the firm’s price target on Bio-Rad (BIO) to $409 from $430 and keeps an Outperform rating on the shares as part of a broader research note previewing Q1 results in the Life Science ...
Business Insider

Bio-Rad Laboratories (BIO) Gets a Buy from RBC Capital

RBC Capital analyst Conor McNamara maintained a Buy rating on Bio-Rad Laboratories (BIO – Research Report) on October 23 and set a price target of $446.00. The company’s shares closed yesterday at ...
Seeking Alpha

Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference

May 01, 2024 9:00 AM ETBio-Rad Laboratories, Inc. (BIO), BIO.B A live webcast and subsequent replay of the event will be available in the Investor Relations section of Bio-Rad’s website at bio-rad.com ...